In conclusion, our preliminary findings provide a pillar for exploring the prognostic value of liquid biopsies for the benefit of PSMA-PET-guided salvage radiotherapy in oligometastatic prostate cancer relapses. The gene discussed is FOLH1; the disease is prostate cancer.